Home > Research > Publications & Outputs > Digital Therapeutic Intervention for Women in t...

Links

Text available via DOI:

View graph of relations

Digital Therapeutic Intervention for Women in the UK Armed Forces Who Consume Alcohol at a Hazardous or Harmful Level: Protocol for a Randomized Controlled Trial

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Digital Therapeutic Intervention for Women in the UK Armed Forces Who Consume Alcohol at a Hazardous or Harmful Level: Protocol for a Randomized Controlled Trial. / Williamson, Grace; Carr, Ewan; Fear, Nicola T et al.
In: JMIR Research Protocols, Vol. 12, e51531, 19.12.2023.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Williamson, G, Carr, E, Fear, NT, Dymond, S, King, K, Simms, A, Goodwin, L, Murphy, D & Leightley, D 2023, 'Digital Therapeutic Intervention for Women in the UK Armed Forces Who Consume Alcohol at a Hazardous or Harmful Level: Protocol for a Randomized Controlled Trial', JMIR Research Protocols, vol. 12, e51531. https://doi.org/10.2196/51531

APA

Williamson, G., Carr, E., Fear, N. T., Dymond, S., King, K., Simms, A., Goodwin, L., Murphy, D., & Leightley, D. (2023). Digital Therapeutic Intervention for Women in the UK Armed Forces Who Consume Alcohol at a Hazardous or Harmful Level: Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 12, Article e51531. https://doi.org/10.2196/51531

Vancouver

Williamson G, Carr E, Fear NT, Dymond S, King K, Simms A et al. Digital Therapeutic Intervention for Women in the UK Armed Forces Who Consume Alcohol at a Hazardous or Harmful Level: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2023 Dec 19;12:e51531. doi: 10.2196/51531

Author

Bibtex

@article{e0fe7fe5cc94431a84499ba68b8662b7,
title = "Digital Therapeutic Intervention for Women in the UK Armed Forces Who Consume Alcohol at a Hazardous or Harmful Level: Protocol for a Randomized Controlled Trial",
abstract = "Alcohol misuse is common in the United Kingdom Armed Forces (UKAF), with prevalence significantly higher than in the general population. To date, digital health initiatives to support alcohol misuse have focused on male individuals, who represent approximately 89% of the UKAF. However, female veterans drink disproportionally more than female members of the public. This 2-arm participant-blinded (single-blinded) confirmatory randomized controlled trial (RCT) aims to assess the efficacy of a brief alcohol intervention (DrinksRation) in reducing weekly self-reported alcohol consumption between baseline and a 3-month follow-up (day 84) among women who have served in the UKAF. In this 2-arm single-blinded RCT, a smartphone app that includes interactive user-focused features tailored toward the needs of female veterans and designed to enhance participants' motivations to reduce the amount of alcohol they consume is compared with the UK Chief Medical Officer guidance on alcohol consumption. The trial will be conducted among women who have served at least 1 day of paid service in the UKAF. Recruitment, consent, and data collection will be carried out automatically through the DrinksRation app or the BeAlcoholSmart platform. The primary outcome is change in self-reported weekly alcohol consumption between baseline (day 0) and the 3-month follow-up (day 84) measured using the Timeline Follow Back for alcohol consumption. The secondary outcome is the change in the Alcohol Use Disorders Identification Test score measured at baseline and 3-month follow-up between the control and intervention groups. The process evaluation measures include (1) app use and (2) usability ratings as measured by the mHealth App Usability Questionnaire. RCT recruitment will begin in January 2024 and last for 5 months. We aim to complete all data collection, including interviews, by May 2024. This study will assess whether a smartphone app tailored to the needs of women who have served in the UKAF is efficacious in reducing self-reported alcohol consumption. If successful, the digital therapeutics platform could be used not only to support women who have served in the UKAF but also for other conditions and disorders. ",
keywords = "study protocol, woman, digital health, United Kingdom, mobile health, women, DrinksRation, mHealth, alcohol, smartphone app, controlled trials, alcohol misuse, mobile app, women veterans, digital therapeutic, mobile phone, mental health, veterans, Armed Forces, randomized controlled trial, RCT",
author = "Grace Williamson and Ewan Carr and Fear, {Nicola T} and Simon Dymond and Kate King and Amos Simms and Laura Goodwin and Dominic Murphy and Daniel Leightley",
year = "2023",
month = dec,
day = "19",
doi = "10.2196/51531",
language = "English",
volume = "12",
journal = "JMIR Research Protocols",
issn = "1929-0748",
publisher = "JMIR Publications Inc.",

}

RIS

TY - JOUR

T1 - Digital Therapeutic Intervention for Women in the UK Armed Forces Who Consume Alcohol at a Hazardous or Harmful Level

T2 - Protocol for a Randomized Controlled Trial

AU - Williamson, Grace

AU - Carr, Ewan

AU - Fear, Nicola T

AU - Dymond, Simon

AU - King, Kate

AU - Simms, Amos

AU - Goodwin, Laura

AU - Murphy, Dominic

AU - Leightley, Daniel

PY - 2023/12/19

Y1 - 2023/12/19

N2 - Alcohol misuse is common in the United Kingdom Armed Forces (UKAF), with prevalence significantly higher than in the general population. To date, digital health initiatives to support alcohol misuse have focused on male individuals, who represent approximately 89% of the UKAF. However, female veterans drink disproportionally more than female members of the public. This 2-arm participant-blinded (single-blinded) confirmatory randomized controlled trial (RCT) aims to assess the efficacy of a brief alcohol intervention (DrinksRation) in reducing weekly self-reported alcohol consumption between baseline and a 3-month follow-up (day 84) among women who have served in the UKAF. In this 2-arm single-blinded RCT, a smartphone app that includes interactive user-focused features tailored toward the needs of female veterans and designed to enhance participants' motivations to reduce the amount of alcohol they consume is compared with the UK Chief Medical Officer guidance on alcohol consumption. The trial will be conducted among women who have served at least 1 day of paid service in the UKAF. Recruitment, consent, and data collection will be carried out automatically through the DrinksRation app or the BeAlcoholSmart platform. The primary outcome is change in self-reported weekly alcohol consumption between baseline (day 0) and the 3-month follow-up (day 84) measured using the Timeline Follow Back for alcohol consumption. The secondary outcome is the change in the Alcohol Use Disorders Identification Test score measured at baseline and 3-month follow-up between the control and intervention groups. The process evaluation measures include (1) app use and (2) usability ratings as measured by the mHealth App Usability Questionnaire. RCT recruitment will begin in January 2024 and last for 5 months. We aim to complete all data collection, including interviews, by May 2024. This study will assess whether a smartphone app tailored to the needs of women who have served in the UKAF is efficacious in reducing self-reported alcohol consumption. If successful, the digital therapeutics platform could be used not only to support women who have served in the UKAF but also for other conditions and disorders.

AB - Alcohol misuse is common in the United Kingdom Armed Forces (UKAF), with prevalence significantly higher than in the general population. To date, digital health initiatives to support alcohol misuse have focused on male individuals, who represent approximately 89% of the UKAF. However, female veterans drink disproportionally more than female members of the public. This 2-arm participant-blinded (single-blinded) confirmatory randomized controlled trial (RCT) aims to assess the efficacy of a brief alcohol intervention (DrinksRation) in reducing weekly self-reported alcohol consumption between baseline and a 3-month follow-up (day 84) among women who have served in the UKAF. In this 2-arm single-blinded RCT, a smartphone app that includes interactive user-focused features tailored toward the needs of female veterans and designed to enhance participants' motivations to reduce the amount of alcohol they consume is compared with the UK Chief Medical Officer guidance on alcohol consumption. The trial will be conducted among women who have served at least 1 day of paid service in the UKAF. Recruitment, consent, and data collection will be carried out automatically through the DrinksRation app or the BeAlcoholSmart platform. The primary outcome is change in self-reported weekly alcohol consumption between baseline (day 0) and the 3-month follow-up (day 84) measured using the Timeline Follow Back for alcohol consumption. The secondary outcome is the change in the Alcohol Use Disorders Identification Test score measured at baseline and 3-month follow-up between the control and intervention groups. The process evaluation measures include (1) app use and (2) usability ratings as measured by the mHealth App Usability Questionnaire. RCT recruitment will begin in January 2024 and last for 5 months. We aim to complete all data collection, including interviews, by May 2024. This study will assess whether a smartphone app tailored to the needs of women who have served in the UKAF is efficacious in reducing self-reported alcohol consumption. If successful, the digital therapeutics platform could be used not only to support women who have served in the UKAF but also for other conditions and disorders.

KW - study protocol

KW - woman

KW - digital health

KW - United Kingdom

KW - mobile health

KW - women

KW - DrinksRation

KW - mHealth

KW - alcohol

KW - smartphone app

KW - controlled trials

KW - alcohol misuse

KW - mobile app

KW - women veterans

KW - digital therapeutic

KW - mobile phone

KW - mental health

KW - veterans

KW - Armed Forces

KW - randomized controlled trial

KW - RCT

U2 - 10.2196/51531

DO - 10.2196/51531

M3 - Journal article

C2 - 38113103

VL - 12

JO - JMIR Research Protocols

JF - JMIR Research Protocols

SN - 1929-0748

M1 - e51531

ER -